Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time

2007 ◽  
Vol 96 (7) ◽  
pp. 569-574 ◽  
Author(s):  
A.P. Schouten van der Velden ◽  
Simon L.B. Van de Vrande ◽  
Carla Boetes ◽  
Peter Bult ◽  
Theo Wobbes
2016 ◽  
Vol 12 (2) ◽  
pp. 995 ◽  
Author(s):  
MaíraTeixeira Dória ◽  
RafaelA. M. Hassan ◽  
JonathanY Maesaka ◽  
MarcosD Ricci ◽  
JoséM Soares ◽  
...  

2010 ◽  
Vol 8 (10) ◽  
pp. 1219-1222 ◽  
Author(s):  
Susan Lester

All breast carcinomas must originate within the ductal/lobular system as carcinoma in situ, but only a subset of these lesions progress to invasive carcinoma. Although pathologic evaluation of the extent of ductal carcinoma in situ (DCIS), the distance to margins, and the degree of margin involvement provides an estimation of the likelihood of residual disease, the amount of disease in the remaining breast cannot be predicted with certainty. Factors other than residual disease may be more important in determining whether patients with DCIS survive or succumb to breast cancer, including biologically new ipsilateral cancers, contralateral cancers, and the degree of resistance of the normal stroma to invasion.


2000 ◽  
Vol 2 (S1) ◽  
Author(s):  
E Robanus-Maandag ◽  
C Bosch ◽  
C Vos ◽  
H Peterse ◽  
M van de Vijver

Sign in / Sign up

Export Citation Format

Share Document